Identification and characterization of a novel homozygous deletion in the α-N-acetylglucosaminidase gene in a patient with Sanfilippo type B syndrome (mucopolysaccharidosis IIIB)

被引:17
|
作者
Champion, Kristen J. [1 ]
Basehore, Monica J. [1 ]
Wood, Tim [1 ]
Destree, Anne [2 ]
Vannuffel, Pascal [2 ]
Maystadt, Isabelle [2 ]
机构
[1] Greenwood Genet Ctr, Greenwood, SC 29646 USA
[2] Inst Pathol & Genet, Ctr Genet Humaine, Gosselies, Charleroi, Belgium
关键词
Sanfilippo; Mucopolysaccharidosis; NAGLU; Deletion; Alu-mediated recombination; LDL RECEPTOR GENE; SYNDROME TYPE-A; LYSOSOMAL STORAGE DISEASES; ALU-ALU RECOMBINATION; FAMILIAL HYPERCHOLESTEROLEMIA; MOLECULAR DEFECTS; ALLELIC HETEROGENEITY; BRITISH-COLUMBIA; MUTATIONS; DUPLICATION;
D O I
10.1016/j.ymgme.2010.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sanfilippo syndrome type B (mucopolysaccharidosis IIIB) is an autosomal recessive disease that is caused by a deficiency of the lysosomal enzyme alpha-N-acetylglucosaminidase (NAGLU). Over 100 different mutations in the NAGLU gene have been identified in Sanfilippo syndrome type B patients; however, no large deletions have been reported. Here we present the first case of a large homozygous intragenic NAGLU gene deletion identified in an affected child of consanguineous parents. Long range and multiplex PCR methods were used to characterize this deletion which encompasses exons 3 and 4 and is 1146 base pairs long. We propose that Alu element-mediated unequal homologous recombination between an Alu-Y in intron 2 and an Alu-Sx in intron 4 is the likely mechanism for this deletion, thereby contributing further insight into the molecular etiology of this disorder and providing additional evidence of its allelic heterogeneity. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 50 条
  • [21] Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts
    Kan, Shih-hsin
    Troitskaya, Larisa A.
    Sinow, Carolyn S.
    Haitz, Karyn
    Todd, Amanda K.
    Di Stefano, Ariana
    Le, Steven Q.
    Dickson, Patricia I.
    Tippin, Brigette L.
    BIOCHEMICAL JOURNAL, 2014, 458 : 281 - 289
  • [22] Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae), first animal model of Sanfilippo syndrome type B.
    Aronovich, EL
    Johnston, JM
    Wang, P
    Giger, U
    Whitley, CB
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 294 - 294
  • [23] Identification of Three Novel Homozygous NAGLU Mutations in Egyptian Patients with Sanfilippo Syndrome B
    Mohammed, Eman E. A.
    Fateen, Ekram M.
    META GENE, 2019, 21
  • [24] Identification and characterisation of an 8.7kb deletion and a novel nonsense mutation in two Italian families with Sanfilippo syndrome type D (mucopolysaccharidosis IIID)
    Beesley, Clare E.
    Concolino, Daniela
    Filocamo, Mirella
    Winchester, Bryan G.
    Strisciuglio, Pietro
    MOLECULAR GENETICS AND METABOLISM, 2007, 90 (01) : 77 - 80
  • [25] Identification and characterization of novel genetic variants in the first Chinese family of mucopolysaccharidosis IIIC (Sanfilippo C syndrome)
    Zhao, Hongjun
    Wang, Lijing
    Zhang, Mengfei
    Wang, Huakun
    Zhang, Sizhe
    Wu, Junjiao
    Tang, Yu
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (08)
  • [26] Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene (ARSB) in Moroccan patient
    Sabir, Es-Said
    Marzouki, Naima
    Lafhal, Karima
    Elqadiry, Rabiy
    Radaa, Nourrdin
    Bouskraoui, Mohammed
    Fdil, Naima
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S128 - S128
  • [27] DETECTION OF THE SANFILIPPO TYPE-B SYNDROME USING RADIOLABELED OLIGOSACCHARIDES AS SUBSTRATES FOR THE ESTIMATION OF ALPHA-N-ACETYLGLUCOSAMINIDASE
    HOPWOOD, JJ
    ELLIOTT, H
    CLINICA CHIMICA ACTA, 1982, 120 (01) : 77 - 86
  • [28] Results of Transpher B, a Multicenter, Single-Dose, Phase 1/2 Clinical Trial of ABO-101 Gene Therapy for Sanfilippo Syndrome Type B (Mucopolysaccharidosis IIIB)
    de Castro, M.
    Flanigan, K.
    Heron, B.
    Muschol, N.
    Couce, M.
    Truxal, K.
    McBride, K.
    Ravelli, C.
    Ammer, L.
    Lindschau, M.
    Fuller, M.
    del Campo, A.
    Ruiz, J.
    ANNALS OF NEUROLOGY, 2021, 90 : S151 - S151
  • [29] Updated Results of Transpher B, a Multicenter, Single-Dose, Phase 1/2 Clinical Trial of ABO-101 Gene Therapy for Sanfilippo Syndrome Type B (Mucopolysaccharidosis IIIB)
    de Castro, Maria J.
    Flanigan, Kevin M.
    Heron, Benedicte
    Muschol, Nicole
    Couce, Maria L.
    Truxal, Kristen V.
    McBride, Kim L.
    Ravelli, Claudia
    Ammer, Luise
    Lindschau, Mona
    Fuller, Maria
    del Campo, Ana B.
    Ruiz, Juan
    MOLECULAR THERAPY, 2021, 29 (04) : 113 - 114
  • [30] Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts
    Boado, Ruben J.
    Lu, Jeff Zhiqiang
    Hui, Eric Ka-Wai
    Lin, Huilan
    Pardridge, William M.
    MOLECULAR PHARMACEUTICS, 2016, 13 (04) : 1385 - 1392